Status:
COMPLETED
HPV Testing for Cervical Cancer Screening Study
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Cervical Cancer Screening
Eligibility:
FEMALE
25-65 years
Phase:
NA
Brief Summary
This is a randomised controlled trial of HPV testing with cytology triage for HPV positive women compared to liquid-based cervical cytology (LBC). Although LBC is not widely used for cervical cancer s...
Detailed Description
There is now an overwhelming body of data to show that HPV testing has the potential to improve the effectiveness of cervical cancer screening programs and thereby reduce rates of cervical cancer. As ...
Eligibility Criteria
Inclusion
- Women from 25 to 65 years of age, registered with the Medical Services Plain in BC attending a collaborating healthcare provider for routine cervical screening in Metro Vancouver or Greater Victoria.
Exclusion
- pregnant
- history of invasive cervical cancer
- no cervix
- HIV positive or on immunosuppressive treatments
- unable or unwilling to give informed consent
- Treatment of moderate or greater dysplasia within last 5 years
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
25223 Patients enrolled
Trial Details
Trial ID
NCT00461760
Start Date
March 1 2007
End Date
June 30 2018
Last Update
June 19 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Laurie Smith
Vancouver, British Columbia, Canada, V5Z 4G8
2
BC Cancer
Vancouver, British Columbia, Canada
3
BC Center for Disease Control
Vancouver, British Columbia, Canada
4
Vancouver General Hospital
Vancouver, British Columbia, Canada